Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using ultra‑high‑frequency ECG to distinguish true LBBB and guide whether left bundle branch or biventricular pacing is best

Official title: The Role of Ultra-high-frequency ECG in the Localization of Left Ventricular Conduction Disorders and Prediction of Response to Resynchronization Therapy

Run by Faculty Hospital Kralovske Vinohrady · NCT07057544 · Data updated 2026-11-12

We will test whether ultra‑high‑frequency ECG can tell 'true' left bundle branch block from other intraventricular conduction delays and see if people with heart failure and a wide non‑RBBB QRS do better with left bundle branch pacing than with biventricular pacing.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorFaculty Hospital Kralovske Vinohrady
Government
Locations1 site (Prague, Česká Republika)
StatusRecruiting
StartedMay 1, 2024
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedJuly 14, 2025
Trial IDNCT07057544 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with ischemic or non‑ischemic cardiomyopathy, NYHA class II–IV, LVEF ≤40%, known coronary angiography, and a non‑RBBB QRS duration >130 ms are the intended candidates.

Probably not a fit

People with right bundle branch block, QRS <130 ms, reversible causes of heart failure, recent major cardiac events or surgery, severe valvular disease requiring intervention, or life expectancy under one year are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional project uses ultra‑high‑frequency ECG (UHF‑ECG) to map ventricular activation patterns and distinguish proximal ('true') LBBB from more distal intraventricular conduction delay (IVCD). Patients with heart failure, LVEF ≤40%, NYHA II–IV and non‑RBBB QRS ≥130 ms will undergo UHF‑ECG and either invasive EP confirmation or validated non‑invasive dyssynchrony assessment, then receive CRT by left bundle branch area pacing (LBBAP) or biventricular pacing (BVP). The study compares electrical dyssynchrony changes, echocardiographic remodeling, and clinical response between groups to see which pacing approach gives greater improvement in patients identified as true LBBB. Pilot data guiding the protocol suggest distinct activation patterns on UHF‑ECG and larger dyssynchrony in true LBBB patients.

Why it matters

Potential benefit: If successful, this approach could help match each patient to the CRT method most likely to improve heart function and symptoms.

How similar studies have gone: Pilot studies and early reports indicate conduction‑system pacing can outperform biventricular pacing in some patients with true LBBB, but randomized evidence is still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* HF due to ischemic or non-ischemic cardiomyopathy
* known coronary angiography
* NYHA II-IV
* LVEF ≤40%
* non-RBBB QRSd lasting \>130 ms (by automated measurement)
* proximal LBBB proved by an invasive EP study or non-invasive dyssynchrony assessment in case such a method is confirmed to be non-inferior to an invasive EP study during the project

Exclusion Criteria:

* Age ˂18 years
* heart failure from reversible causes
* Moderate to severe aortic stenosis
* pregnancy
* active myocarditis
* hypertrophic cardiomyopathy
* cardiac valve surgery in the last three months
* myocardial infarction, PCI, or CABG in the last three months
* severe valvular disease requiring intervention
* severe atherosclerotic disease of the aorta and/or femoral arteries
* life expectancy ˂1 year
* known medical condition or contraindication causing potential complications for EP study

Where it's running

  • Faculty Hospital Kralovske Vinohrady
    Prague, Česká Republika, Czechia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.